| AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib |
Globe Newswire |
09/22 |
08:55 |
| LPL Financial Welcomes Cornerstone Advisors and Clear Pointe Wealth Management |
Globe Newswire |
09/22 |
08:55 |
| OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health |
Globe Newswire |
09/22 |
08:40 |
| Yuethai Hydraulics Marks 20 Years of Innovation and Reliability |
Globe Newswire |
09/22 |
08:36 |
| Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services |
Globe Newswire |
09/22 |
08:33 |
| Colorado PPE Opens New Colorado Facility to Deliver Firefighter PPE Care Above and Beyond Standard Compliance |
Globe Newswire |
09/22 |
08:31 |
| Birchtech to Participate in Upcoming Investor Conferences |
Globe Newswire |
09/22 |
08:31 |
| Zeo Energy Enters Cooperation Agreement with Ewyze to Develop Integrated Off-Grid Power and Data-Center Infrastructure |
Globe Newswire |
09/22 |
08:30 |
| Grayscale Investments Introduces Grayscale AI Compute ETF (Ticker: GCPU), Targeting the Infrastructure Powering AI's Growth |
Globe Newswire |
09/22 |
08:30 |
| Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach |
Globe Newswire |
09/22 |
08:30 |
| Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder |
Globe Newswire |
09/22 |
08:30 |
| Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback |
Globe Newswire |
09/22 |
08:30 |
| Nightfood Holdings Inc. (OTCQB: NGTF) Announces Formation of Manufacturing Subsidiary, Built with Taiwan-Based Manufacturing Partner |
Globe Newswire |
09/22 |
08:30 |
| Funnel enters a new era as multifamily’s first front-office-only AI platform |
Globe Newswire |
09/22 |
08:30 |
| Superstar Platforms Announces Agreement to Acquire TitlePal, Inc. |
Globe Newswire |
09/22 |
08:30 |
| Higher Images Named to Pittsburgh Business Times’ 2026 Largest Advertising, Marketing and Public Relations Firms List |
Globe Newswire |
09/22 |
08:30 |
| Fiserv Expands Clover Footprint in Canadian Sports and Entertainment |
Globe Newswire |
09/22 |
08:30 |
| Other World Computing (OWC) Wins Tech & Learning Awards of Excellence: Back to School 2026! |
Globe Newswire |
09/22 |
08:30 |
| Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria |
Globe Newswire |
09/22 |
08:30 |
| Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015 |
Globe Newswire |
09/22 |
08:30 |
| Caseware Named as Finalist in Three Categories at the 2026 A.I. Awards |
Globe Newswire |
09/22 |
08:30 |
| Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices |
Globe Newswire |
09/22 |
08:30 |
| VistaShares Introduces the Shield Family of ETFs, Providing The Better Buffer Advisors and Investors Have Been Seeking |
Globe Newswire |
09/22 |
08:30 |
| Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib |
Globe Newswire |
09/22 |
08:30 |
| Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium |
Globe Newswire |
09/22 |
08:30 |
